The FDA‐Approved Antiviral Raltegravir Inhibits Fascin1‐Dependent Invasion of Colorectal Tumor Cells In Vitro and In Vivo

dc.contributor.author	Montoro García, Silvia
dc.date.accessioned	2024-01-25T08:03:47Z
dc.date.available	2024-01-25T08:03:47Z
dc.date.issued	2021
dc.description.discipline	Farmacia	es
dc.description.discipline	Medicina	es
dc.identifier.doi	10.3390/cancers13040861..	es
dc.identifier.uri	http://hdl.handle.net/10952/7103
dc.issue.number	4	es
dc.journal.title	Cancers (Basel).	es
dc.language.iso	en	es
dc.relation.projectID	Diseño y caracterización de inhibidores de fascina para el bloqueo de invasión y metástasis en cáncer colorrectal" [PI18/00144] (01/01/2019- 31/12/2021)	es
dc.rights	Atribución-NoComercial-CompartirIgual 4.0 Internacional	*
dc.rights	Attribution-NonCommercial-NoDerivatives 4.0 Internacional	*
dc.rights.accessRights	open access	es
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/4.0/	*
dc.title	The FDA‐Approved Antiviral Raltegravir Inhibits Fascin1‐Dependent Invasion of Colorectal Tumor Cells In Vitro and In Vivo	es
dc.type	journal article	es
dc.volume.number	13	es
dspace.entity.type	Publication
person.affiliation.name	Universidad Católica San Antonio de Murcia
person.identifier.orcid	0000-0002-1948-1022
relation.isAuthorOfPublication	19355a0a-e9b4-45cc-8589-7812bebec813
relation.isAuthorOfPublication.latestForDiscovery	19355a0a-e9b4-45cc-8589-7812bebec813

Files

Now showing 1 - 1 of 1